The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models. (October 2022) - Joe, R.; Matsumura, Y.; Siddiqui, A.; Foulks, J.; Beg, M.; Thompson, J.; Yamamoto, N.; Spira, A.; Sarantopoulos, J.; Melear, J.; Lou, Y.; Lebedinsky, C.; et al.